Patient Guide: A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 162 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06335303
Status: ACTIVE_NOT_RECRUITING
Condition: Idiopathic Pulmonary Fibrosis
Phase: PHASE2

Where You Can Participate

This study is available at 162 locations across the country.

Top locations include:
  • • Birmingham, Alabama
  • • Lakewood, Colorado
  • • Kissimmee, Florida
  • • And 159 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) - Join Clinical Trial NCTNCT06335303

How to Join This Clinical Trial - NCTNCT06335303

Learn how to participate in this PHASE2 trial studying an investigational therapy for Idiopathic Pulmonary Fibrosis. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Idiopathic Pulmonary Fibrosis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Idiopathic Pulmonary Fibrosis
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT06335303 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 162 locations. Find a study site near you:

Clinical Research Site

Birmingham, Alabama 35233 - United States

Status: Contact for availability

Clinical Research Site

Lakewood, Colorado 80228 - United States

Status: Contact for availability

Clinical Research Site

Kissimmee, Florida 34746 - United States

Status: Contact for availability

Clinical Research Site

Pensacola, Florida 32503 - United States

Status: Contact for availability

Clinical Research Site

West Des Moines, Iowa 50266 - United States

Status: Contact for availability

Clinical Research Site

Warren, Michigan 48088 - United States

Status: Contact for availability

Clinical Research Site

Gulfport, Mississippi 39501 - United States

Status: Contact for availability

Clinical Research Site

New Bern, North Carolina 28562 - United States

Status: Contact for availability

Clinical Research Site

Winston-Salem, North Carolina 27103 - United States

Status: Contact for availability

Clinical Research Site

DuBois, Pennsylvania 15801 - United States

Status: Contact for availability

And 152 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Idiopathic Pulmonary Fibrosis:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships